Serum myoglobin, but not lipopolysaccharides, is predictive of AMPH-induced striatal neurotoxicity

NeuroToxicology

Volumn 37, Issue , 2013, Pages 40-50

  Levi, Mark S ^a   Patton, Ralph E ^a   Hanig, Joseph P ^b   Tranter, Karen M ^a   George, Nysia I ^a   James, Laura P ^c,d   Davis, Kelly J ^a   Bowyer, John F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

Amphetamine; Kidney; Lipopolysaccharides; Liver; Muscle; Neurotoxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHETAMINE; CREATININE; DOPAMINE; LIPOPOLYSACCHARIDE; MYOGLOBIN; NITROGEN; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CREATININE BLOOD LEVEL; DOPAMINE BLOOD LEVEL; HISTOPATHOLOGY; HYPERTHERMIA; IMMUNE RESPONSE; KIDNEY DYSFUNCTION; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LIVER NECROSIS; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

AMPHETAMINE; ANIMALS; BASAL GANGLIA; BIOLOGICAL MARKERS; BODY TEMPERATURE REGULATION; DISEASE MODELS, ANIMAL; DOPAMINE; FEVER; HYPERTHERMIA, INDUCED; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; MUSCLE, SKELETAL; MYOGLOBIN; NECROSIS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; UP-REGULATION;

EID: 84877329269     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.04.003     Document Type: Article

References (57)

1. Bailey M.T., Engler H., Sheridan J.F. Stress induces the translocation of cutaneous and gastrointestinal microflora to secondary lymphoid organs of C57BL/6 mice. J Neuroimmunol 2006, 171:29-37.
2. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W., et al. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 1994, 268:1571-1580.
3. Bowyer J.F., Frame L.T., Clausing P., Nagamoto-Combs K., Osterhout C.A., Sterling C.R., et al. Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. J Pharmacol Exp Ther 1998, 286:1074-1085.
4. Bowyer J.F., Holson R.R. Methamphetamine and amphetamine neurotoxicity: characteristics, interactions with body temperature and possible mechanisms. Handbook of neurotoxicology 1995, 845-870. Marcel Dekker Inc., New York. L.W. Chang, R.S. Dyer (Eds.).
5. Bowyer J.F., Peterson S.L., Rountree R.L., Tor-Agbidye J., Wang G.J. Neuronal degeneration in rat forebrain resulting from d-amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res 1998, 809:77-90.
6. Bowyer J.F., Tank A.W., Newport G.D., Slikker W., Ali S.F., Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 1992, 260:817-824.
7. Bowyer J.F., Thomas M.T., Schmued L.C., Ali S.F. Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures and the blood-brain barrier. Ann N Y Acad Sci 2008, 1139:127-139.
8. Bellomo R., Daskalakis M., Parkin G., Boyce N. Myoglobin clearance during acute continuous hemodiafiltration. Intensive Care Med 1991, 17:509-510.
9. Broening H.W., Pu C., Vorhees C.V. Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse 1997, 27:153-160.
10. Cass W.A., Manning M.W., Dugan M.T. Effects of neurotoxic doses of methamphetamine on potassium and amphetamine evoked overflow of dopamine in the striatum of awake rats. Neurosci Lett 1998, 248:175-178.
11. Clausing P., Bowyer J.F. Time course of brain temperature and caudate/putamen microdialysate levels of amphetamine and dopamine in rats after multiple doses of d-amphetamine. Ann N Y Acad Sci 1999, 890:495-504.
12. Clausing P., Gough B., Holson R.R., Slikker W., Bowyer J.F. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 1995, 274:614-621.
13. Dunn A.J., Ando T., Brown R.F., Berg R.D. HPA axis activation and neurochemical responses to bacterial translocation from the gastrointestinal tract. Ann N Y Acad Sci 2003, 992:21-29.
14. Eisch A.J., Schmued L.C., Marshall J.F. Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse 1998, 30:329-333.
15. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007, 47:681-698.
16. Goto S., Korematsu K., Oyama T., Yamada K., Hamada J., Inoue N., et al. Neuronal induction of 72-kDa heat shock protein following methamphetamine-induced hyperthermia in the mouse hippocampus. Brain Res 1993, 626:351-356.
17. Groebler L.K., Liu J., Shanu A., Codd R., Witting P.K. Comparing the potential renal protective activity of desferrioxamine B and the novel chelator desferrioxamine B-N-(3-hydroxyadamant-1-yl)carboxamide in a cell model of myoglobinuria. Biochem J 2011, 435:669-677.
18. Halpin L.E., Yamamoto B.K. Peripheral ammonia as a mediator of methamphetamine neurotoxicity. J Neurosci 2012, 32:13155-13163.
19. Hess A., Desiderio C., McAuliffe W.G. Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies. J Neurocytol 1990, 19:338-342.
20. Hirsiger S., Simmen H.P., Werner C.M., Wanner G.A., Rittirsch D. Danger signals activating the immune response after trauma. Mediat Inflamm 2012, 2012:315941.
21. Ishigami A., Tokunaga I., Gotohda T., Kubo S. Immunohistochemical study of myoglobin and oxidative injury-related markers in the kidney of methamphetamine abusers. Leg Med (Tokyo) 2003, 5(1):42-48.
22. Jayanthi S., Deng X., Noailles P.A., Ladenheim B., Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 2004, 18:238-251.
23. Kalant H., Kalant O.J. Death in amphetamine users: causes and rates. Can Med Assoc J 1975, 112(3):299-304.
24. Kelly K.A., Miller D.B., Bowyer J.F., O'Callaghan J.P. Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine. J Neurochem 2012, 122(5):995-1009. 10.1111/j.1471-4159.2012.07864.x.
25. Levi M.S., Divine B., Hanig J.P., Doerge D.R., Vanlandingham M.M., George N.I., et al. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle. Neurotoxicol Teratol 2012, 34:253-262.
26. Lu D., Das D.K. Induction of differential heat shock gene expression in heart, lung, liver, brain and kidney by a sympathomimetic drug, amphetamine. Biochem Biophys Res Commun 1993, 192:808-812.
27. McGee S.M., McGee D.N., McGee M.B. Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation. Am J Forensic Med Pathol 2004, 25(4):334-337.
28. Miller D.B., O'Callaghan J.P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994, 270:752-760.
29. Miller E.K., Raese J.D., Morrison-Bogorad M. Expression of heat shock protein 70 and heat shock cognate 70 messenger RNAs in rat cortex and cerebellum after heat shock or amphetamine treatment. J Neurochem 1991, 56:2060-2071.
30. Miller M.A., Coon T.P. Re: delayed ischemic stroke associated with methamphetamine use. J Emerg Med 2006, 31(3):305-306. [author reply 306].
31. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994, 270:741-751.
32. O'Callaghan J.P., Miller D.B. Neurotoxic effects of substituted amphetamines in rats and mice. Handbook of neurotoxicology 2001, 269-301. Humana Press Inc., Totowa, NJ. E.J. Massaro (Ed.).
33. Paller M.S. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol 1988, 255:F539-F544.
34. Quinton M.S., Yamamoto B.K. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 2006, 8:E337-E347.
35. Raghubeer E.V., Matches J.R. Temperature range for growth of Escherichia coli serotype O157:H7 and selected coliforms in E. coli medium. J Clin Microbiol 1990, 28:803-805.
36. Ramesh G., Reeves W.B. Inflammatory cytokines in acute renal failure. Kidney Int 2004, 66:S56-S61.
37. Ricaurte G.A., McCann U.D. Recognition and management of complications of new recreational drug use. Lancet 2005, 365:2137-2145.
38. Richards J.R., Johnson E.B., Stark R.W., Derlet R.W. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 1999, 17(7):681-685.
39. Rothrock J.F., Rubenstein R., Lyden P.D. Ischemic stroke associated with methamphetamine inhalation. Neurology 1988, 38(4):589-592.
40. Schmued L.C., Bowyer J.F. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res 1997, 759:135-140.
41. Seiden L.S., Fischman M.W., Schuster C.R. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1976, 1:215-219.
42. Seiden L.S., Sabol K.E. Neurotoxicity of methamphetamine-related drugs and cocaine. Handbook of neurotoxicology. 1995, 824-844. Marcel Dekker, Inc., New York, Basel, Hong Kong. Chang LWaRSD (Ed.).
43. Selkirk G.A., McLellan T.M., Wright H.E., Rhind S.G. Mild endotoxemia, NF-kappaB translocation, and cytokine increase during exertional heat stress in trained and untrained individuals. Am J Physiol Regul Integr Comp Physiol 2008, 295:R611-R623.
44. Sriram K., Miller D.B., O'Callaghan J.P. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 2006, 96:706-718.
45. Stephans S.E., Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 1994, 17:203-209.
46. Tang D., Kang R., Coyne C.B., Zeh H.J., Lotze M.T. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 2012, 249:158-175.
47. Thomas D.M., Francescutti-Verbeem D.M., Liu X., Kuhn D.M. Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment - an oligonucleotide microarray approach. J Neurochem 2004, 88:380-393.
48. Thomas D.M., Kuhn D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res 2005, 1050:190-198.
49. Thomas D.M., Walker P.D., Benjamins J.A., Geddes T.J., Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 2004, 311:1-7.
50. Thomas M., George N.I., Patterson T.A., Bowyer J.F. Amphetamine and environmentally induced hyperthermia differentially alter the expression of genes regulating vascular tone and angiogenesis in the meninges and associated vasculature. Synapse 2009, 63:881-894.
51. Thomas M., George N.I., Saini U.T., Patterson T.A., Hanig J.P., Bowyer J.F. Endoplasmic reticulum stress responses differ in meninges and associated vasculature, striatum, and parietal cortex after a neurotoxic amphetamine exposure. Synapse 2010, 64:579-593.
52. Tokunaga I., Kubo S., Ishigami A., Gotohda T., Kitamura O. Changes in renal function and oxidative damage in methamphetamine-treated rat. Leg Med (Tokyo) 2006, 8:16-21.
53. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001, 158:377-382.
54. White S.R. Amphetamine toxicity. Semin Respir Crit Care Med 2002, 23:27-36.
55. Winslow B.T., Voorhees K.I., Pehl K.A. Methamphetamine abuse. Am Fam Physician 2007, 76(8):1169-1174.
56. Yamaguchi T., Kuraishi Y., Minami M., Nakai S., Hirai Y., Satoh M. Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus. Neurosci Lett 1991, 128:90-92.
57. Yuan J., Hatzidimitriou G., Suthar P., Mueller M., McCann U., Ricaurte G. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys. J Pharmacol Exp Ther 2006, 316:1210-1218.